HIGHLIGHTS
- who: Payaningal R. Somanath and collaborators from the Department of Clinical and Administrative Pharmacy, College of Pharmacy, University of Georgia, MetasTx LLC, Basking Ridge, NJ, USA have published the research: Targeting P21-Activated Kinase-1 for Metastatic Prostate Cancer, in the Journal: Cancers 2023, 15, 2236. of 11/04/2023
- what: The current review describes PCa pathophysiology, challenges in the management of mPCa patients, current and future therapies for mPCa patients to reduce overall mortality, and discusses the potential therapeutic benefits and novel strategies for targeting PAKs in the management of advanced, mPCa patients.
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.